Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerConversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Overcoming Real World Challenges of LDL-C Management: Looking Beyond Statin Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Facing Heart Failure: Trends in the United States
Norbert Moskovits, MD, FACC, FACCP
PeerThe Disease Burden and Epidemiology of Heart Failure
Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN
PeerThe Importance of Making an Accurate and Timely Heart Failure Diagnosis
Pamela Kushner, MD, FAAFP
PeerThe Pathophysiology and Pathoetiology of Heart Failure
Stephen Greene, MD
PeerHeart Failure Disease State Awareness
Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN
PeerGuideline Directed Medical Therapy for the Management of Heart Failure
Stephen Greene, MD
PeerThe Interconnectivity of The Cardio-Renal-Metabolic Systems and Associated Comorbidities
Pamela Kushner, MD, FAAFP
PeerCritical Considerations of Residual CV Risk in Patients With T2D & ASCVD
Breaking Down Barriers for PAH Patient Risk Assessment Through EHR Systems
A Treatment for NYHA Class II-III Obstructive HCM Patients